Octreotide-Treated Diabetes Accompanied by Endogenous Hyperinsulinemic Hypoglycemia and Protein-Losing Gastroenteropathy

Occurrence of hypoglycemia in diabetes patients is very rare. We report here a case of frequent hypoglycemic attacks caused by inappropriate endogenous hyperinsulinemia in a female patient with poorly controlled diabetes and protein-losing gastroenteropathy. The blood glucose profiles of the patient were unstable. Results of the fasting test performed to investigate the cause of hypoglycemia suggested endogenous hyperinsulinism. Repeated selective arterial calcium injection tests suggested that hyperinsulinemia might be extrapancreatic in origin. However, efforts to detect a responsible lesion such as insulinoma were unsuccessful. Octreotide was used for the treatment of hypoglycemia and protein-losing gastroenteropathy. After treatment, although her leg edema caused by hypoalbuminemia persisted, hypoglycemia almost disappeared.

[1]  Y. Ogawa,et al.  Diagnosis and management of insulinoma. , 2013, World journal of gastroenterology.

[2]  Kohjiro Ueki,et al.  Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus , 2010, Journal of diabetes investigation.

[3]  J. Holst,et al.  Little enhancement of meal‐induced glucagon‐like peptide 1 secretion in Japanese: Comparison of type 2 diabetes patients and healthy controls , 2010, Journal of diabetes investigation.

[4]  S. Libutti,et al.  Localization of insulinomas to regions of the pancreas by intraarterial calcium stimulation: the NIH experience. , 2009, The Journal of clinical endocrinology and metabolism.

[5]  P. Caron,et al.  Short‐ and long‐term somatostatin analogue treatment in patients with hypoglycaemia related to endogenous hyperinsulinism , 2008, Clinical endocrinology.

[6]  G. O’Malley,et al.  Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia. , 2008, Annals of emergency medicine.

[7]  Mark Ellrichmann,et al.  Predictors of Incretin Concentrations in Subjects With Normal, Impaired, and Diabetic Glucose Tolerance , 2008, Diabetes.

[8]  Daniel B. Jones,et al.  Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. , 2007, The Journal of clinical endocrinology and metabolism.

[9]  P. Caron,et al.  Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism. , 2007, European journal of endocrinology.

[10]  D. Drucker.  The role of gut hormones in glucose homeostasis. , 2007, The Journal of clinical investigation.

[11]  F. Ashcroft,et al.  Potent and selective activation of the pancreatic beta-cell type KATP channel by two novel diazoxide analogues , 2003, Diabetologia.

[12]  J. Holst,et al.  Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. , 2003, The Journal of clinical endocrinology and metabolism.

[13]  Mark R. Burge,et al.  Severe Hypoglycemia in Adults , 2003, Reviews in Endocrine and Metabolic Disorders.

[14]  W. Yap,et al.  Hypoglycaemia from islet cell hyperplasia and nesidioblastosis in a patient with type 2 diabetes mellitus--a case report. , 2000, Annals of the Academy of Medicine, Singapore.

[15]  S. Fan,et al.  Value of intra‐arterial calcium‐stimulated venous sampling for regionalization of pancreatic insulinomas , 2000, Surgery.

[16]  M. Farthing,et al.  Octreotide in the treatment of intestinal lymphangiectasia. , 1998, European journal of gastroenterology & hepatology.

[17]  S. Tsagarakis,et al.  Regionalization of occult pancreatic insulinomas with the arterial stimulation venous sampling (ASVS) technique , 1997, Clinical endocrinology.

[18]  S. Libutti,et al.  Intraarterial calcium stimulation and intraoperative ultrasonography in the localization and resection of insulinomas. , 1997, Surgery.

[19]  H. Koshiyama,et al.  Localization of insulinomas by selective intraarterial calcium injection. , 1996, The Journal of clinical endocrinology and metabolism.

[20]  J. Škrha,et al.  Comparison of Insulin Sensitivity in Patients with Insulinoma and Obese Type 2 Diabetes Mellitus , 1996, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[21]  T. Schacker,et al.  Clinical and Epidemiologic Features of Primary HIV Infection , 1996, Annals of Internal Medicine.

[22]  D. Fraker,et al.  Localization of Insulinomas to Regions of the Pancreas by Intra-arterial Stimulation with Calcium , 1995, Annals of Internal Medicine.

[23]  M. Imamura,et al.  Usefulness of selective arterial calcium injection test and secretin test in patients with insulinoma , 1994 .

[24]  C. W. Garner,et al.  Insulin stimulates the degradation of IRS-1 in 3T3-L1 adipocytes. , 1993, Biochemical and biophysical research communications.

[25]  J. Holst,et al.  Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy , 1991, Digestive Diseases and Sciences.

[26]  G. Giustina,et al.  Effect of a new long-acting somatostatin analogue (SMS 201–995) on glycemic and hormonal profiles in insulin-treated type II diabetic patients , 1988, Journal of endocrinological investigation.

[27]  L. Kvols,et al.  Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. , 1986, The New England journal of medicine.

[28]  J. Farndon,et al.  Diazoxide in the management of patients with insulinoma , 1986, World Journal of Surgery.

[29]  T. A. Schultz,et al.  Clinical evaluation of somatostatin as a potential adjunct to insulin in the management of diabetes mellitus , 1977, Diabetologia.

[30]  H. Kuzuya,et al.  Hypoglycemia and endogenous hyperinsulinism complicating diabetes mellitus. Application of the C-peptide assay to diagnosis and therapy. , 1975, The American journal of medicine.

[31]  J. Howard,et al.  Hyperinsulinism and islet cell tumors of the pancreas; with 398 recorded tumors. , 1950, International abstracts of surgery.

[32]  G. Laidlaw.  Nesidioblastoma, the islet tumor of the pancreas. , 1938, The American journal of pathology.

[33]  W. Knoefel,et al.  Adult diffuse nesidioblastosis: genetically or environmentally induced? , 2008, Human pathology.

[34]  T. Yamanaka,et al.  Usefulness of the combination of pre- and intraoperative selective intraarterial calcium injection to detect residual insulinomas. , 2001, Internal medicine.

[35]  K. Ibukuro.  Vascular anatomy of the pancreas and clinical applications , 2001, International journal of gastrointestinal cancer.

[36]  E. Rubin.  Hypoglycemic disorders. , 1995, The New England journal of medicine.

[37]  S. Bloom,et al.  Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases. , 1985, Gastroenterology.